Thomas Trilling
About Thomas Trilling
Thomas Trilling serves as the VP and Commercial Head of Europe at Nektar Therapeutics. He has extensive experience in the pharmaceutical industry, having held various leadership roles at companies such as Amgen, Sobi, and Basilea Pharmaceutica, where he focused on commercial strategies and market leadership.
Work at Nektar Therapeutics
Thomas Trilling serves as the Vice President and Commercial Head of Europe at Nektar Therapeutics. He has held this position since 2021, operating from Zug, Switzerland. In this role, he is responsible for overseeing commercial strategies and operations across various European markets. His leadership is focused on driving growth and market presence for Nektar's portfolio in a competitive landscape.
Previous Experience in the Pharmaceutical Industry
Thomas Trilling has extensive experience in the pharmaceutical industry, having worked in various leadership roles. He was the Business Unit Director for Nephrology at Amgen from 2003 to 2007. He later served as General Manager at Basilea Pharmaceutica International AG from 2007 to 2012. His tenure at Sobi included multiple roles, such as General Manager for the D-A-CH region and Global Launch Lead for Emapalumab. He also worked at Agios Pharmaceuticals as Vice President and General Manager for the DACH region from 2019 to 2021.
Education and Expertise
Thomas Trilling studied at the University of Münster, where he earned his MD in Medicine from 1990 to 1996. He also attended Gymnasium Canisianum in Lüdinghausen. His educational background provides a strong foundation for his expertise in the pharmaceutical sector, particularly in pricing and reimbursement processes across Europe.
Achievements in Commercial Strategy
Throughout his career, Thomas Trilling has successfully managed and finalized 21 out of 24 pricing and reimbursement processes for various products across Europe. He has led the development and execution of commercial strategies that resulted in rapid market uptake and leadership in Germany for three different indications. His ability to achieve accelerated growth in product volume, even in the face of generic competition, highlights his strategic acumen.
International Experience
Thomas Trilling has direct working experience in 12 countries, including Germany, Austria, Switzerland, France, and the United States. His focus has been on pricing and reimbursement processes as well as in-/out-licensing projects. This international exposure has equipped him with a comprehensive understanding of diverse market dynamics and regulatory environments within the pharmaceutical industry.